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By collecting and analyzing health information from patients with SCD over time, 
SCDC can identify critical gaps in diagnosis, treatment, and access to care and 
can inform decision-makers about how these gaps can be filled through policy 
changes, improved health care practices, and education.
The goal of the Georgia Sickle Cell Data Collection (SCDC) Program is to improve 
the quality of life, life expectancy, and the health of individuals with sickle cell 
disease (SCD). 
404.413.0314
ghpc.gsu.edu
ghpc@gsu.edu
Available SCDC data
As the data coordinating center for SCDC in 
Georgia, the Georgia Health Policy Center 
at Georgia State University is assembling 
a comprehensive dataset that enables 
surveillance of sickle cell–related diagnosis 
and health care utilization since 2004 for more 
than 10,000 patients. Data are collected from:
• Newborn screening results
• Death records
• Clinical records from the sickle cell treatment centers
• Administrative claims from Georgia’s Medicaid, Children’s Health Insurance 
Program, and the State Health Benefit Plan
• Hospital and emergency department discharge data
Why is SCDC important?
SCDC data can help answer questions about access to care, health care utilization 
and costs, and quality of care, as well as how these patterns vary by age, sex, 
genotype, geography, and health insurance. This information can assist in:
• Estimating the cost impacts of policy decisions
• Informing allocation of outpatient and telehealth services
• Targeting patient and family education materials and case management
• Focusing provider education and training
SCDC analysis can inform action:
• Educate — To shape individual or institutional practices or behaviors
• Decide — To inform policy, service, and resource allocation decisions 
• Learn — To answer research questions to inform future actions
• Target — To identify a population for interventions, services, or education
Stakeholders who can drive action using SCDC data include:
National SCDC priority areas:
• Aging sickle cell population — 
Documentation of complications, 
comorbidities, and outcomes over 
patients’ life course can inform standards 
of care, interventions, reimbursement, 
and health care policy.
• Geography of population — Data can 
identify differences in access to care, 
health care utilization, and quality of care 
by patient location.
• Hispanic population — Data can better identify individuals with SCD born 
outside of the United States and estimate the prevalence in the Hispanic 
population.
• Transition from pediatric to adult care — Data enables examination of the 
factors that may be associated with increases in symptoms, complications, 
and poorer outcomes seen during the transition to adult care.
• Utilization — SCDC enables comparisons between low and high utilizers by 
diagnosis, procedure or intervention, and outcomes over time. Such analysis 
may inform clinical practice and patient self-care tied to better outcomes 
and lower costs.
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The Georgia Health Policy Center is the data-coordinating 
center for multi-institutional projects focused on surveillance 
of and health promotion for individuals with blood 
disorders, including SCD.
Learn more: ghpc.gsu.edu/project/hemoglobin-disorders-
data-coordinating-center/
Contact Angie Snyder (angiesnyder@gsu.edu) if you would 
like to use SCDC Georgia data for your research or planning.
